Menu
GWAS Study

Genome-wide association analyses identify distinct genetic architectures for early-onset and late-onset depression.

Shorter JR, Pasman JA, Kurvits S et al.

41233554 PubMed ID
GWAS Study Type
153532 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SJ
Shorter JR
PJ
Pasman JA
KS
Kurvits S
JA
Jangmo A
NJ
Naamanka J
HA
Harder A
HE
Hagen E
KK
Kowalec K
FN
Frilander N
ZR
Zetterberg R
MJ
Meijsen JJ
GJ
Gådin JR
BJ
Bergstedt J
XY
Xiong Y
HS
Hägg S
LM
Landén M
RC
Rück C
WJ
Wallert J
SA
Skalkidou A
KE
Koch E
AB
Akdeniz BC
FO
Frei O
HI
Hovatta I
RT
Reichborn-Kjennerud T
WT
Werge TM
SP
Sullivan PF
AO
Andreassen OA
TM
Tesli M
LK
Lehto K
BA
Buil A
LY
Lu Y
Chapter II

Abstract

Summary of the research findings

Major depressive disorder (MDD) is a common and heterogeneous disorder of complex etiology. Studying more homogeneous groups stratified according to clinical characteristics, such as age of onset, can improve the identification of the underlying genetic causes and lead to more targeted treatment strategies. We leveraged Nordic biobanks with longitudinal health registries to investigate differences in the genetic architectures of early-onset (eoMDD; n = 46,708 cases) and late-onset (loMDD; n = 37,168 cases) MDD. We identified 12 genomic loci for eoMDD and two for loMDD. Overall, the two MDD subtypes correlated moderately (genetic correlation, rg = 0.58) and differed in their genetic correlations with related traits. These findings suggest that eoMDD and loMDD have partially distinct genetic signatures, with a specific developmental brain signature for eoMDD. Importantly, we demonstrate that polygenic risk scores (PRS) for eoMDD predict suicide attempts within the first 10 years after the initial diagnosis: the absolute risk for suicide attempt was 26% in the top PRS decile, compared to 12% and 20% in the bottom decile and the intermediate group, respectively. Taken together, our findings can inform precision psychiatry approaches for MDD.

46,708 European ancestry cases, 106,824 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

153532
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Sweden, Norway, Finland, Denmark, Estonia
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.